arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BioNexus Gene Lab Corp

BGLC

$0.93 ▼ -0.13 (-12.38%) at close

9 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

BioNexus Gene Lab Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth -21.9% ↘

Op. Margin -39.9% ↘

ROIC -34.4% ↘

FCF / Share —

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 4, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$7.42M

↓ -21.9% —

Net Income Profit after all expenses

$-2.98M

↓ -86.7% —

Operating Margin Operating profit as % of sales

-39.9%

↓ -141.3% 6th

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Revenue Growth YoY (%)	-21.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-374%)	-2.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-133%)	-10.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-232%)	-18.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-328%)	17.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+116%)	8872.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+110800%)	-40.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-603%)	—	—
Net Income Growth YoY (%)	-86.7% Weak ↑ Weak Improving Year-over-year change in net income	39.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-638.6% Weak Weak Year-over-year change in net income	N/M	-31.3% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
Revenue CAGR 3Y (%)	-12.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-5.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	341.5% Excellent Excellent Compound annual revenue growth over 3 years	297.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-8.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	137.1% Excellent Excellent Compound annual revenue growth over 5 years	115.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Operating Margin (%) (%)	-39.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-366%)	-16.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-210%)	-26.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-277%)	-2.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	7.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-47%)	11.2% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-25%)	-217.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1548%)	28.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+88%)	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.2% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	-27.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-40.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-435%)	-16.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-240%)	-26.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-324%)	-3.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-127%)	5.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-53%)	9.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-20%)	-194.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1718%)	12.5% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	—
FCF Margin (%) (%)	-25.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-24.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-20.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	5.0% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	0.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-181.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-147.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.45x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-1.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-11.86x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Return on Invested Capital (%)	-34.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	18.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	15.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	3.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-32.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	11.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	12.6% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-22.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	3.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-34.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-27.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	10.5% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-30%)	16.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	-22.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	1.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-88%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Interest Coverage (x)	-431.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-168.29x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-292.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	81.39x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	112.60x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-54.63x Weak Weak Operating income divided by interest expense Optimal: > 5x	13.86x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-2.49M	$-2.89M	—	—	—	$-2.79M	—	—	—

📊 What does each share earn? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Book Value per Share (USD)	$3.56	$4.63	$0.55	$0.46	$0.04	$0.04	$0.01	$0.02	—
Tangible Book Value per Share (USD)	$3.56	$4.63	$0.55	$0.46	$0.04	$0.04	$0.01	$0.02	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Working Capital (USD)	$4.93M	$5.48M	$6.42M	$4.02M	$4.82M	$4.61M	$831.00K	$1.24M	—
Total Equity (USD)	$8.61M	$8.32M	$9.66M	$6.67M	$7.18M	$6.66M	$1.12M	$1.52M	$94.63K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jan 1, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$7.42M	$9.51M	$9.77M	$10.93M	$13.36M	$11.39M	$126.95K	$212.33K	—
Depreciation Expense (USD)	$111.87K	$104.16K	$83.25K	$91.43K	$91.28K	$90.79K	$41.71K	$40.61K	—
Net Income, GAAP (USD)	$-2.98M	$-1.60M	$-2.63M	$-355.97K	$751.57K	$1.09M	$-246.47K	$26.45K	—
Operating Cash Flow (USD)	$-1.84M	$-2.09M	$-1.82M	$551.82K	$9.16K	$552.68K	$-217.27K	$-274.08K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 35 quarters

BioNexus Gene Lab Corp

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BGLC with peers